You are here: Home: BCU 6 | 2006: Faculty disclosures

CONTENT VALIDATION AND DISCLOSURES

Research To Practice is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess potential conflicts of interest with faculty, planners and managers of CME activities. Real or apparent conflicts of interest are identified and resolved by a peer review content validation process. The content of each activity is reviewed by both a member of the scientific staff and an external independent reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations.

The scientific staff and consultants for Research To Practice are involved in the development and review of content for educational activities and report the following real or apparent conflicts of interest for themselves (or their spouses/partners) that have been resolved through a peer review process: Richard Kaderman, PhD, Neil Love, MD, Mary Beth Nierengarten, Douglas Paley, Margaret Peng, Lilliam Sklaver Poltorack, PharmD, Ginelle Suarez, Chris Thomson, MD, MS, Erin Wall and Kathryn Ault Ziel, PhD — no real or apparent conflicts of interest to report; Marie Bialek, PharmD — Freelance/Contract Medical Writer: McNeil Consumer & Specialty Pharmaceuticals, Janssen Pharmaceutica Products LP; salary (spouse): AstraZeneca Pharmaceuticals LP; Sally Bogert, RNC, WHCNP — shareholder of Amgen Inc and Genentech BioOncology. Research To Practice receives education grants from Abraxis Oncology, Amgen Inc, AstraZeneca Pharmaceuticals LP, Bayer Pharmaceuticals Corporation/Onyx Pharmaceuticals Inc, Genentech BioOncology/OSI Pharmaceuticals Inc, Genomic Health Inc, Roche Laboratories Inc and Sanofi-Aventis, who have no influence on the content development of our educational activities.

In addition, the following faculty (and their spouses/partners) have reported real or apparent conflicts of interest that have been resolved through a peer review process:

Dr Burstein Speakers Bureau: Amgen Inc, Genentech BioOncology. Dr GeyerConsulting Fees: Genentech BioOncology. Dr Hayes — No financial interests or affiliations to disclose. Dr HendersonFees for Non-CME Services Received Directly from Commercial Interest or their Agents: Abraxis Oncology; Contracted Research: Abraxis Oncology; Ownership Interest: Johnson & Johnson Pharmaceuticals. Dr Lippman — No financial interests or affiliations to disclose. Dr OsborneRoyalty: Lippincott Williams & Wilkins; Consulting Fees: Pfizer Inc; Contracted Research: AstraZeneca Pharmaceuticals LP. Dr RobertsonConsulting Fees: AstraZeneca Pharmaceuticals LP, Novartis Pharmaceuticals, Pfizer Inc, Schering AG; Fees for Non-CME Services Received Directly from Commercial Interest or Their Agents: AstraZeneca Pharmaceuticals LP, Novartis Pharmaceuticals, Pfizer Inc; Contracted Research: AstraZeneca Pharmaceuticals LP, Novartis Pharmaceuticals, Schering AG. Dr SmithConsulting Fees: Eli Lilly and Company, GlaxoSmithKline, Novartis Pharmaceuticals, Pfizer Inc, Roche Laboratories Inc; Speakers Bureau: AstraZeneca Pharmaceuticals LP, Novartis Pharmaceuticals, Roche Laboratories Inc. Dr Vicini — No financial interests or affiliations to disclose. Dr Winer Consulting Fees: AstraZeneca Pharmaceuticals LP, Genentech BioOncology, Genomic Health Inc, Roche Laboratories Inc, Sanofi-Aventis; Fees for Non-CME Services Received Directly from Commercial Interest or Their Agents: Genomic Health Inc; Contracted Research: AstraZeneca Pharmaceuticals LP, Genentech BioOncology, Roche Laboratories Inc, Sanofi-Aventis.


This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantors.

BCU Think Tank

CME Test Online

Home · Search

Editor’s Note:
Reality check

Interviews
Marc E Lippman, MD
- Select publications

C Kent Osborne, MD
- Select publications

I Craig Henderson, MD
- Select publications

Charles E Geyer Jr, MD
- Select publications

Frank A Vicini, MD
- Select publications

Miami Beach Cancer Conference Tumor Panel Discussion on Systemic Therapy of Metastatic Disease
- Select publications


CME Information

Faculty Disclosures

Editor's Office

Media Center
PDF
Media Center
Podcast
Previous Editions